|
1
|
Heart failure…what of the future? AIHW
Bull. 19:2003.
|
|
2
|
Sochalski J, Jaarsma T, Krumholz HM,
Laramee A, McMurray JJV, Naylor MD, Rich MW, Riegel B and Stewart
S: What works in chronic care management: The case of heart
failure. Health Aff (Millwood). 28:179–189. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Azevedo PS, Polegato BF, Minicucci MF,
Paiva SA and Zornoff LA: Cardiac remodeling: Concepts, clinical
impact, pathophysiological mechanisms and pharmacologic treatment.
Arq Bras Cardiol. 106:62–69. 2016.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
4
|
Konstam MA, Kramer DG, Patel AR, Maron MS
and Udelson JE: Left ventricular remodeling in heart failure:
Current concepts in clinical significance and assessment. JACC
Cardiovasc Imaging. 4:98–108. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Masci PG, Schuurman R, Andrea B, Ripoli A,
Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD,
et al: Myocardial fibrosis as a key determinant of left ventricular
remodeling in idiopathic dilated cardiomyopathy: A
contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc
Imaging. 6:790–799. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu F, Na L, Li Y and Chen L: Roles of the
PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and
tumours. Cell Biosci. 10(54)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang Y, Zhou ZW, Jin H, Hu C, He ZX, Yu
ZL, Ko KM, Yang T, Zhang X, Pan SY and Zhou SF: Schisandrin B
inhibits cell growth and induces cellular apoptosis and autophagy
in mouse hepatocytes and macrophages: Implications for its
hepatotoxicity. Drug Des Devel Ther. 9:2001–2027. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang W, Wu Z, Yang K, Han Y, Chen Y, Zhao
W, Huang F, Jin Y and Jin W: BMI1 promotes cardiac fibrosis in
ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling
pathway. Am J Physiol Heart Circ Physiol. 316:H61–H69.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Singla DK: Akt-mTOR pathway inhibits
apoptosis and fibrosis in doxorubicin-induced cardiotoxicity
following embryonic stem cell transplantation. Cell Transplant.
24:1031–1042. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Leask A: TGFbeta, cardiac fibroblasts, and
the fibrotic response. Cardiovasc Res. 74:207–212. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hu X, Zhang H, Li X, Li Y and Chen Z:
Activation of mTORC1 in fibroblasts accelerates wound healing and
induces fibrosis in mice. Wound Repair Regen. 28:6–15.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Osada H and Takahashi T: MicroRNAs in
biological processes and carcinogenesis. Carcinogenesis. 28:2–12.
2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shivdasani RA: MicroRNAs: Regulators of
gene expression and cell differentiation. Blood. 108:3646–3653.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yuan J, Liu H, Gao W, Zhang L, Ye Y, Yuan
L, Ding Z, Wu J, Kang L, Zhang X, et al: MicroRNA-378 suppresses
myocardial fibrosis through a paracrine mechanism at the early
stage of cardiac hypertrophy following mechanical stress.
Theranostics. 8:2565–2582. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Verjans R, Peters T, Beaumont FJ, van
Leeuwen R, van Herwaarden T, Verhesen W, Munts C, Bijnen M, Henkens
M, Diez J, et al: MicroRNA-221/222 family counteracts myocardial
fibrosis in pressure overload-induced heart failure. Hypertension.
71:280–288. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pegtel DM and Gould SJ: Exosomes. Annu Rev
Biochem. 88:487–514. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Edgar JR: Q&A: What are exosomes,
exactly? BMC Biol. 14(46)2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bhome R, Del Vecchio F, Lee GH, Bullock
MD, Primrose JN, Sayan AE and Mirnezami AH: Exosomal microRNAs
(exomiRs): Small molecules with a big role in cancer. Cancer Lett.
420:228–235. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Matsumura T, Sugimachi K, Iinuma H,
Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano
Y, et al: Exosomal microRNA in serum is a novel biomarker of
recurrence in human colorectal cancer. Br J Cancer. 113:275–281.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen JJ, Zhao B, Zhao J and Li S:
Potential roles of exosomal MicroRNAs as diagnostic biomarkers and
therapeutic application in Alzheimer's disease. Neural Plast.
2017(7027380)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang VK, Loughran KA, Meola DM, Juhr CM,
Thane KE, Davis AM and Hoffman AM: Circulating exosome microRNA
associated with heart failure secondary to myxomatous mitral valve
disease in a naturally occurring canine model. J Extracell
Vesicles. 6(1350088)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tian ZQ, Jiang H and Lu ZB: MiR-320
regulates cardiomyocyte apoptosis induced by ischemia-reperfusion
injury by targeting AKIP1. Cell Mol Biol Lett.
23(41)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ren XP, Wu J, Wang X, Sartor MA, Jones K,
Qian J, Nicolaou P, Pritchard TJ and Fan GC: MicroRNA-320 is
involved in the regulation of cardiac ischemia/reperfusion injury
by targeting heat-shock protein 20. Circulation. 119:2357–2366.
2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chinese Society of Cardiology of Chinese
Medical Association; Editorial Board of Chinese Journal of
Cardiology. Chinese guidelines for the diagnosis and treatment of
heart failure 2014. Zhonghua Xin Xue Guan Bing Za Zhi. 42:98–122.
2014.PubMed/NCBI(In Chinese).
|
|
27
|
Caraballo C, Desai NR, Mulder H, Alhanti
B, Wilson FP, Fiuzat M, Felker GM, Piña IL, O'Connor CM, Lindenfeld
J, et al: Clinical implications of the New York heart association
classification. J Am Heart Assoc. 8(e014240)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang Y, Yan LS, Ding Y, Cheng BCY, Luo G,
Kong J, Liu TH and Zhang SF: Edgeworthia gardneri (Wall.) meisn.
Water extract ameliorates palmitate induced insulin resistance by
regulating IRS1/GSK3β/FoxO1 signaling pathway in human HepG2
hepatocytes. Front Pharmacol. 10(1666)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang Z, Shi J, Gao Y, Cui C, Zhang S, Li
J, Zhou Y and Cui Q: HMDD v3.0: A database for experimentally
supported human microRNA-disease associations. Nucleic Acids Res.
47:D1013–D1017. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Agarwal V, Bell GW, Nam J and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
ELife. 4(e05005)2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tokar T, Pastrello C, Rossos AEM, Abovsky
M, Hauschild AC, Tsay M, Lu R and Jurisica I: mirDIP
4.1-integrative database of human microRNA target predictions.
Nucleic Acids Res. 46:D360–D370. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kanehisa M, Furumichi M, Sato Y,
Ishiguro-Watanabe M and Tanabe M: KEGG: Integrating viruses and
cellular organisms. Nucleic Acids Res. 49:D545–D551.
2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Villacorta H and Maisel AS: Soluble ST2
testing: A promising biomarker in the management of heart failure.
Arq Bras Cardiol. 106:145–152. 2016.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
38
|
Wojtczak-Soska K, Pietrucha T, Sakowicz A
and Lelonek M: Soluble ST2 protein in chronic heart failure is
independent of traditional factors. Arch Med Sci. 9:21–26.
2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tsuji K, Sakata Y, Nochioka K, Miura M,
Yamauchi T, Onose T, Abe R, Oikawa T, Kasahara S, Sato M, et al:
Characterization of heart failure patients with mid-range left
ventricular ejection fraction-a report from the CHART-2 Study. Eur
J Heart Fail. 19:1258–1269. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Holland R, Rechel B, Stepien K, Harvey I
and Brooksby I: Patients' self-assessed functional status in heart
failure by New York heart association class: A prognostic predictor
of hospitalizations, quality of life and death. J Card Fail.
16:150–156. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Glaubitz M, Block S, Witte J, Empen K,
Gross S, Schlicht R, Weitmann K, Klingel K, Kandolf R, Hoffmann W,
et al: Stiffness of left ventricular cardiac fibroblasts is
associated with ventricular dilation in patients with recent-onset
nonischemic and nonvalvular cardiomyopathy. Circ J. 78:1693–1700.
2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kumar D, Gupta D, Shankar S and Srivastava
RK: Biomolecular characterization of exosomes released from cancer
stem cells: Possible implications for biomarker and treatment of
cancer. Oncotarget. 6:3280–3291. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Puzar Dominkus P, Stenovec M, Sitar S,
Lasič E, Zorec R, Plemenitaš A, Žagar E, Kreft M and Lenassi M:
PKH26 labeling of extracellular vesicles: Characterization and
cellular internalization of contaminating PKH26 nanoparticles.
Biochim Biophys Acta Biomembr. 1860:1350–1361. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Fan H, Ma L, Fan B, Wu J, Yang Z and Wang
L: Role of PDGFR-β/PI3K/AKT signaling pathway in PDGF-BB induced
myocardial fibrosis in rats. Am J Transl Res. 6:714–723.
2014.PubMed/NCBI
|
|
45
|
Willis O, Choucair K, Alloghbi A, Stanbery
L, Mowat R, Brunicardi FC, Dworkin L and Nemunaitis J: PIK3CA gene
aberrancy and role in targeted therapy of solid malignancies.
Cancer Gene Ther. 27:634–644. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lieb V, Weigelt K, Scheinost L, Fischer K,
Greither T, Marcou M, Theil G, Klocker H, Holzhausen HJ, Lai X, et
al: Serum levels of miR-320 family members are associated with
clinical parameters and diagnosis in prostate cancer patients.
Oncotarget. 9:10402–10416. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen C, Wang Y, Yang S, Li H, Zhao G, Wang
F, Yang L and Wang DW: MiR-320a contributes to atherogenesis by
augmenting multiple risk factors and down-regulating SRF. J Cell
Mol Med. 19:970–985. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yin Z, Zhao Y, Li H, Yan M, Zhou L, Chen C
and Wang DW: miR-320a mediates doxorubicin-induced cardiotoxicity
by targeting VEGF signal pathway. Aging (Albany NY). 8:192–207.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sommariva E, D'Alessandra Y, Farina FM,
Casella M, Cattaneo F, Catto V, Chiesa M, Stadiotti I, Brambilla S,
Russo AD, et al: MiR-320a as a potential novel circulating
biomarker of arrhythmogenic cardiomyopathy. Sci Rep.
7(4802)2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Salloum-Asfar S, Satheesh NJ and Abdulla
SA: Circulating miRNAs, small but promising biomarkers for autism
spectrum disorder. Front Mol Neurosci. 12(253)2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ponikowski P, Voors AA, Anker SD, Bueno H,
Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP,
Jankowska EA, et al: 2016 ESC guidelines for the diagnosis and
treatment of acute and chronic heart failure: The task force for
the diagnosis and treatment of acute and chronic heart failure of
the European society of cardiology (ESC) developed with the special
contribution of the heart failure association (HFA) of the ESC. Eur
Heart J. 37:2129–2200. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lotierzo M, Dupuy AM, Kalmanovich E,
Roubille F and Cristol JP: sST2 as a value-added biomarker in heart
failure. Clin Chim Acta. 501:120–130. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ozturk TC, Unluer E, Denizbasi A, Guneysel
O and Onur O: Can NT-proBNP be used as a criterion for heart
failure hospitalization in emergency room? J Res Med Sci.
16:1564–1571. 2011.PubMed/NCBI
|
|
54
|
Turchinovich A, Weiz L, Langheinz A and
Burwinkel B: Characterization of extracellular circulating
microRNA. Nucleic Acids Res. 39:7223–7233. 2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wang B, Zhang A, Wang H, Klein JD, Tan L,
Wang ZM, Du J, Naqvi N, Liu BC and Wang XH: miR-26a limits muscle
wasting and cardiac fibrosis through exosome-mediated microRNA
transfer in chronic kidney disease. Theranostics. 9:1864–1877.
2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Yang J, Yu X, Xue F, Li Y, Liu W and Zhang
S: Exosomes derived from cardiomyocytes promote cardiac fibrosis
via myocyte-fibroblast cross-talk. Am J Transl Res. 10:4350–4366.
2018.PubMed/NCBI
|
|
57
|
Bang C, Batkai S, Dangwal S, Gupta SK,
Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, et al:
Cardiac fibroblast-derived microRNA passenger strand-enriched
exosomes mediate cardiomyocyte hypertrophy. J Clin Invest.
124:2136–2146. 2014.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wang L, Liu J, Xu B, Liu YL and Liu Z:
Reduced exosome miR-425 and miR-744 in the plasma represents the
progression of fibrosis and heart failure. Kaohsiung J Med Sci.
34:626–633. 2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Lv T, Du Y, Cao N, Zhang S, Gong Y, Bai Y,
Wang W and Liu H: Proliferation in cardiac fibroblasts induced by
β1-adrenoceptor autoantibody and the underlying mechanisms. Sci
Rep. 6(32430)2016.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Januzzi JL, Mebazaa A and Di Somma S: ST2
and prognosis in acutely decompensated heart failure: The
international ST2 consensus panel. Am J Cardiol. 115 (Suppl
7):26B–31B. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ock S, Lee WS, Ahn J, Kim HM, Kang H, Kim
HS, Jo D, Abel ED, Lee TJ and Kim J: Deletion of IGF-1 receptors in
cardiomyocytes attenuates cardiac aging in male mice.
Endocrinology. 157:336–345. 2016.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Wang WW, Zhang FL, Chen JH, Chen XH, Fu
FY, Tang MR and Chen LL: Telmisartan reduces atrial arrhythmia
susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS
pathways in spontaneously hypertensive rats. Can J Physiol
Pharmacol. 93:657–665. 2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
McMullen JR, Sherwood MC, Tarnavski O,
Zhang L, Dorfman AL, Shioi T and Izumo S: Inhibition of mTOR
signaling with rapamycin regresses established cardiac hypertrophy
induced by pressure overload. Circulation. 109:3050–3055.
2004.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Sun S, Hu Y, Zheng Q, Guo Z, Sun D, Chen
S, Zhang Y, Liu P, Lu J and Jiang J: Poly(ADP-ribose) polymerase 1
induces cardiac fibrosis by mediating mammalian target of rapamycin
activity. J Cell Biochem. 120:4813–4826. 2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Laplante M and Sabatini DM: mTOR signaling
at a glance. J Cell Sci. 122:3589–3594. 2009.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Memmott RM and Dennis PA: Akt-dependent
and -independent mechanisms of mTOR regulation in cancer. Cell
Signal. 21:656–664. 2009.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Rao KB, Malathi N, Narashiman S and Rajan
ST: Evaluation of myofibroblasts by expression of alpha smooth
muscle actin: A marker in fibrosis, dysplasia and carcinoma. J Clin
Diagn Res. 8:ZC14–ZC17. 2014.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Zhang K, Rekhter MD, Gordon D and Phan SH:
Myofibroblasts and their role in lung collagen gene expression
during pulmonary fibrosis. A combined immunohistochemical and in
situ hybridization study. Am J Pathol. 145:114–125. 1994.PubMed/NCBI
|
